Acute coronary syndrome: Role of the telomere dynamic by Behjati, M
African Journal of Biotechnology Vol. 8 (18), pp. 2595-2605, 3 May, 2010     
Available online at http://www.academicjournals.org/AJB 












Resident of cardiology, Isfahan University of Medical Sciences, Isfahan, Iran.  
E-mail: behjati@med.mui.ac.ir. Fax: +983112222255. 
 
Accepted 18 March, 2010 
 
Telomeres, or historically named "terminal genes" are first discovered by Muller working on fruit fly in 
1930s. Since then, the great progress was made in understanding the consequences of telomere 
erosion on the human health and disease states, as age related vascular diseases. The overlapping 
links between telomere dynamics in endothelial cells, endothelial progenitor cells and other cells laid in 
the vessel wall made telomere regulation as a hub node in keeping vascular health. Shortest telomeres 
paralleled with the advent of coronary artery diseases and its related risk factors, is well explainable by 
"Telomere hypothesis". But this needs further studies to determine the real state of short telomere 
length in atherosclerosis: marker or risk factor? As a marker, leukocyte telomere length was used in 
mirroring mean telomere length of the whole organism, but there are some debates about the best cell 
reflecting the exact telomere length. Impact of telomere biology on vascular system in the progression 
and development of atherosclerosis delights its targeting as a new therapeutic option for 
cardiovascular diseases. This needs in depth elucidation of the underlying mechanisms of telomere 
erosion in vascular beds.  
 





Telomeres, or historically named "terminal genes", are 
highly specialized structures at the end of chromosomes, 
which were first discovered by Muller working on the fruit 
fly in 1930s (Bailey and Goodwin, 2004). The role of 
these protective caps became more evident with the 
raised hypothesis of "problem of the terminal replication" 
by James (1972) and Olovnikov (1973) (Verdun and 




Abbreviations: ATM, Ataxia telangiectasia mutated; ADP, 
adenosine diphosphate; PARPS, poly(ADP-
ribosyl)polymerases; vWF, von Willebrand factor; TERT, 
Telomerase Reverse Transcriptase; TEP, telomerase 
associated protein; EPCS, endothelial progenitor cells; EVA, 
early vascular aging; TMM, telomere maintenance mechanisms; 
SSDB, single-stranded DNA breaks; eNOS, endothelial nitric 
oxide synthase; RNP, ribonucleoprotein; HR, homologues 
recombination; NHEJR, non-homologues end joining 
replication; ALT, alternative lengthening of telomere; LTL, 
Leukocyte telomere length; STELA, single telomere length 
analysis. 
TTAGGG tracts make a D-loop-T-loop by folding 3  
terminal overhang, which resembles a shelter for the 
susceptible ends (Rahman et al., 2008). This hanging 
end is structurally constructed by multiple adjacent 
quadruplex produced by intra-telomeric G base pairing 
(Oganesian, 2007). The presence of the 3  overhang is 
not helping without the cap. Uncapped 3  overhang acts 
as an invasive end for recombination, in a cell-cycle-
specific period, as shown in yeasts (DuBois, 2002). 
Establishing a capped telomere, different proteins should 
participate. Shelterin is a complex built with six proteins: 
TRF1, TRF2, TIN2, Rap1, TPP1 and POT1 (de Lange, 
2005). This complex makes the DNA repair system to 
ignore telomere as a double stranded DNA break point 
(Blackburn, 1991) (Greider, 1996). This magic structure 
needs a facilitator in keeping both length and function. 
(TTAGGG)n bricks are added to the telomeres through a 
ratcheting mechanism, repetitive dissociation from the 
newly synthesized telomeres, realigning and adding 
another six nucleotides at a time, via the action of 
telomerase (Artandi, 2006). Telomerase, a ribonucleo-
protein composed  of  catalytic  subunit  (TERT),  its  own 




RNA template (TERC) and telomerase associated protein 
(TEP) which interacts dynamically with other components 
of telomere complex (Prathapam et al., 2005).  
Unfortunately, telomeres are unstable structures. Any 
failure in these highly ordinate process, results in 
telomere deregulation: pace of aging and age related 
diseases; as atherosclerosis. Atherosclerosis, nation's 
number one killer, is mainly considered to be an age-
related vascular disease (Burton et al., 2009). Recently 
paid attention "telomere hypothesis", running besides the 
previous concept of "response to injury", reminds athero-
sclerosis as a "telomere related disease" (Minamino and 
Komuro, 2006; Zhang et al., 2008). Telomeres, in their 
very ends, are cutting edges for the beginning of the 
disease chain. These critically short telomeres; which 
seen in the forced regions susceptible to atherosclerosis; 
promote chromosomal fusion implicated in the evolution 
of complex karyotypes, by the presence of Anaphase 
bridge, telomere associations and diccentric chromo-
somes (Wen et al., 2006). Telomere-driven cytogenetic 
evolutions can also evolve in TP-53 competent cells, 
which initiate the formation of cytogenetic aberrations 
(Wen et al., 2006).  
Terminal ends of the cells, skilled in communication, 
tune the vascular behavior. Unwind vascular Olovnikov's 
clocks lead to cellular senescence and apoptosis, via 
activation of P16 (INK4a) signaling pathway: main gate-
keeper of telomere-driven chromosomal abnormalities 
(Jacobs and de Lange, 2004) (Wen et al., 2006). Subse-
quently, vascular wall players, endothelial and smooth 
muscle cells, fall in replicative senescence: permanent 
exit from cell cycle, which is associated with disturbed 
cellular homeostasis (Hayashi et al., 2008). Senescent 
endothelial cell loses power to keep its function in its 
environment. It loses its attachment to its neighbors and 
this endothelial cell depletion makes a pro-coagulable 
state by exposing the thrombogenic sub-endothelial sur-
face (Williamson, 2007). Detached endothelial cell makes 
a fenestra within the vessel wall, as a wound.  
Risk factors for atherosclerosis accelerate telomere 
shortening in endothelial cells that are continuously expo-
sed to stressors. But the impact of the ageing and local 
and systemic stressors on systemic telomere length is a 
virtue, which affects all players of athermanous plaque, 
besides endothelial cells, as immune and regenerative 
stem cells. Telomere and telomerase biology are some 
what different in various cells in the process of athero-
sclerosis. 
In contrast to endothelial cells, telomerase activation 
and telomere stabilization occur in smooth muscle cells 
and T cell lymphocytes in the early stages of athero-
sclerosis (Minamino et al., 2001; Liu et al., 2005). 
Activated telomerase in smooth muscle cells, mainly 
attributed to the increased TERT phosphorylation indu-
ced by hypoxia and nuclear localization, afford them with 
increased life span and proliferative capacity (Minamino 





origin of atherosclerosis" which is enhanced replication of 
monoclonal smooth muscle cells (Murry, 1997). This may 
be a defense mechanism in order to contract the wound 
in the vessel wall, but is not a permanent event. And 
finally, smooth muscle cells reach their critical telomere 
length which enters them to the senescent phase, due to 
the repeated cell divisions and atherogenic micro-
environment. Enhanced senescence and apoptosis in the 
plaque's fibrous cap, smooth muscle cells and fibroblasts, 
make the lipid core unopposed as seen in the plaques 
vulnerable to rupture (Matthews et al., 2006). Further 
telomere shortening in endothelial cells in atherosclerotic 
plaques result in endothelial cell sloughing. The weakly 
protected plaque undergoes rupture with a little force as 
disrupted shear stress (Fukumoto et al., 2008). Telomere 
dysfunction in immune and inflammatory cells as 
monocytes/ macrophages impairs their functions 
(Damjanovic et al., 2007). These functionally impaired 
cells, as seen in lipid-laden macrophages, are unable to 
engulf lipid droplet thoroughly accumulated in the vessel 
wall and thus triggers lesional formation and progression 
(Schrijvers et al., 2007). Mentioned telomerase activation 
and subsequent enhanced replication of T cell lympho-
cytes seems to be due to the stimulatory effect of the 
exposed atherogenic antigens. But in the same direction 
with smooth muscle cells, in the late stages of athero-
sclerosis, increased apoptosis of T cell lymphocytes 
occurs. Overalls, at the late stages of atherosclerosis, the 
percentage of apoptotic cells is in its peak and 
telomerase activity in its nadir (Liu et al., 2005). These 
dynamic alterations in telomere length and cellular via-
bility make a stable plaque vulnerable to rupture. In this 
setting, a brief viral or bacterial infection, mainly flu virus, 
Herpes virus, Cytomegalovirus, Epstein-Barr virus, 
Chlamydia Trachomatis, Chlamydia and Mycoplasma 
pneumonia worsen the subtle vascular disease by exa-
cerbation of inflammatory load on the previously dama-
ged endothelial cells (Muhlestein and Anderson, 2003). 
Therefore, the presence of a supportive "telomere cap" 
means a supportive "plaque cap", which determines the 
plaque fate.  
Endothelial progenitor cells (EPCs), bone marrow-
derived stem cells long favored as Rosetta stone in 
angiogenesis, are recruited to the intima in response to 
the signals derived from denuded intima layer and deta-
ched endothelial cells (Song, 2009). Senescent EPCs, 
impaired functionally and numerically, are less poten-
tiated to reach the damaged vessel wall, which leads to 
non-healing intimal wound and progression of athero-
sclerotic plaques inward the lumen. But this is not the 
whole. In the middle stages of atherosclerosis, fibrofatty 
stage, fibrocytes, bone-marrow derived mescenchymal 
stem cells migrate to the adventitia after maturation via 
the interaction between chemokine (CC motif) receptor 
7(CCR7) and its ligands in secondary lymphoid organs: 
Chemokine (C-C motif) ligand 19 and 21(Bellini, 2007) 





adventitia secret transforming growth factor-  and matrix 
metalloproteinase 9; two key elements in adventitia 
originated angiogenesis and lead to adventitia thickness 
(Metz CN. 2003) (Hartlapp, 2001). Fibrocytes differentiate 
into fibroblasts and myofibroblasts in media and trans-
migrate toward intima and exert as protective cap for the 
plaque lipid core (Brigitte, 2007; Medbury, 2008). 
Fibrocyte senescence leads to adventitia shrinkage which 
indirectly results in further lumen narrowing due to the 
nature of negative remodeling (Deiner, 2007). Since 
fibrocytes actively participate in the formation of fibrous 
plaque, senescent fibrocytes lead to uncapped plaque 
which promotes inflammation and lumen narrowing: 
dynamic movement toward total vessel obstruction and 
untoward coronary event (Medbury, 2008).  
By mentioned links, the relation between telomere 
shortening and recently paid attention subject of early 
vascular aging (EVA) syndrome are explainable. But the 
underlying mechanisms of accelerated telomere erosion 
proceeding endothelial cell dysfunction are more com-
plex. The bottle neck of telomere loss is endothelial cell 
failure to keep telomere maintenance mechanisms 
(TMM). A brief review of the telomere structure and its 
requirements will shed lights to the paths lead to telomere 
dysfunction. 
The average telomere length, like the average height, 
is heritable genetically, which highlights again the impact 
of genetic reservoir on the prevalence of cardiovascular 
diseases (Salpea, 2008). So, offsprings of parents with 
longer average telomere length and older fathers have 
longer terminal ends (Manestar-Blazic, 2004; Unryn, 
200). Perhaps, it is longer telomere length in females 
which protect them against cardiovascular diseases 
(Terry, 2008). The association between short telomeres 
length and predisposition to atherosclerosis, as deter-
mined by carotid artery intimal medial thickness was 
demonstrated in the Framingham Offspring Study (FOS) 
(O'Donnell, 2008). As shown in Framingham Heart Study 
(FHS), shorter telomeres were seen with higher ratio of 
rennin/ angiotensin (Vasan, 2008). Critically length 
telomeres showed an inverse correlation with pulse 
pressure, biologic marker of vascular aging and predictor 
of increased mortality rate, in men (Benetos, 2001). This 
relation was inconsistent in females (Benetos, 2001). 
Effects of telomere length on the future cardiovascular 
risks have been determined in the West of Scotland 
Primary Prevention Study: a fate determining length 
(Brouilette, 2007).  
Oxidative stress has direct effect on telomere length 
(Kurz et al., 2004). This effect has been determined 
through the formation of oxidatively modified Guanine 
bases, 8 -OxodG, in telomeric versus non-telomeric DNA 
(Kawanishi and Oikawa, 2004). The presence of these 
unpaired bases, interfering with replication fork, makes 
single-stranded DNA breaks (SSDB), but telomeric DNA 
in contrast to genomic is unable to repair the breaks 
(Dobbs et al., 2008).  Decreased  telomere  length  in  the  




setting of excessive psychological stress, bipolar mood 
disorders and schizophrenia is attributed to the great 
burden of oxidative burst, mainly hydroxyl radicals 
(Fuster and Andres, 2006; Simon et al., 2006; Yu et al., 
2008; Stephanson, 2003). Chronic oxidative stress is also 
an explanation for decreased telomere length in situa-
tions with increased risk of atherosclerosis as smoking, 
homosysteinemia, autoimmune disease, inflammatory 
bowel disease and chronic obstructive pulmonary dis-
ease (Morla, 2006; Richards et al., 2008; Gupta and 
Gollapudi, 2006; Risques et al., 2008). Alternatively, stra-
tegies to decrease oxidative stress (e.g. by over-
expression of anti-oxidant enzymes or consumption of 
anti-oxidant agents as statins and N-acetyl systein) were 
associated with telomere rejuvenation (Mahmoudi et al., 
2008; Voghel et al., 2008). Despite of major cause of 
decreased telomere length in atherogenic environment, 
the increased inflammation due to increased Leptin level 
and positive energy balance lead to telomere exhaustion 
in obess cases (Das et al., 2009; Lionetti et al., 2009). 
These factors, in addition to insulin resistance explain 
short telomeres in Diabetes and metabolic syndrome 
(Adaikalakoteswari et al., 2005).  
Short telomeres may be partly due to the reduced 
telomerase activity, but interestingly the same patho-
logies affect both of them, as hypertension, oxidative 
stresses and increased C- reactive protein levels (Perez-
Rivero et al., 2006; Satoh et al., 2008; Fujii et al., 2006). 
The impressive effect of atherogenic-hemodynamic on 
telomere length maintenance is recognizable by consi-
dering the shorter telomere length of the common iliac 
arteries with great burden of shear stress compared to 
internal thoracic artery (Chang and Harley, 1995). The 
cause of telomerase inactivation is not thoroughly under-
stood in some settings. However, decreased telomerase 
activity is associated with senescent phenotype endo-
thelial cells which means reduced NO production, 
impaired endothelial nitric oxide synthase (eNOS) activity 
and disturbed vascular integrity (Matsushita et al., 2001; 
Kurz, 2003). Mutually emerging evidences suggest that 
increased eNOS activity or NO bioavailability activate 
telomerase, with consequent transformation from pro-
atherogenic to anti-atherogenic phenotype (Farsetti, 
2009). Not only endothelial cell, but also EPCs are affect-
ted by impaired telomerase activity as shown by decrea-
sed population of functional EPCs with increased 
apoptosis rate among them (Fujii et al., 2006).  
The overrate role of telomerase in telomere elongation 
caused overlooking its other probable roles. Recently, 
telomerase have been found to activate stem cells 
through mechanism which does not require its telomere-
lengthening functions. Certainly, telomerase have more 
potentials than base-addition which are not yet 
understood. In this state, we just can expect that 
telomerase impairment plays great role, beside telomere 
attrition, in the development and progression of 
atherosclerosis.  




Anyway, telomerase, driving factor in telomere 
maintenance, like other proteins, is regulated in different 
steps, as transcription, mRNA processing, translation, 
post-translational modifications, telomerase localization 
and access to telomeres. Down regulated telomerase 
expression in endothelial cells and plaque smooth muscle 
cells, forces them into crisis (Cao et al., 2002). Alterna-
tively, telomerase expression alone rescued plaque 
smooth muscle cell senescence despite short telomeres, 
which means plaque rescue from rupture (Matthews et 
al., 2006). Telomerase expression is controlled via the 
positive and negative regulators, located in the TERT 
promoter. The combinatorial eNOS/ERalpha complex at 
the TERT estrogen response element site explains telo-
merase down regulation in endothelial cells with reduced 
nitric oxide (NO) environment (Zeng and Xu, 2008). The 
role of epistatic changes on the TERT promoters as DNA 
methylation is not yet evident in the process of endo-
thelial cell dysfunction. Telomerase gene, by 15 exon-
intron boundaries, possesses 9 isoforms, which the only 
functional one is full length variant and other deletion (, 
, + and ) and insertion variants (I, II, III and IV) are 
totally frustrated by getting early terminate codons with 
no translation (Saeboe-Larssen et al., 2006). The role of 
alternative splicing in the impairment of rabbit telomerase 
activity was ruled out, but needs to be determined in 
human telomerase by further studies (Behjati et al., 
2007). TERT- provided active-site residues for 
magnesium-catalyzed nucleotide addition are situated in 
the cleft of a structure that resembles a half-open right 
hand (Lue, 1999; Weilbaecher and Lundblad, 1999). 
Mutations in its invariant aspartate residues result in 
reduced telomerase activity (Weilbaecher and Lundblad, 
1999). The rate limiting telomerase catalytic subunit, 
TERT, needs post translational phosphorylation for its 
proper action, mainly by PI 3 kinase/AKT, which is 
impaired due to oxidative stresses, decreased NO levels, 
impaired superoxide dismutase and so on (Ram et al., 
2009; Zhou et al., 2009) This golden key pathway makes 
a hub node regulating telomerase activity, NO bio-
availability and EPC differentiation, which seems a thera-
peutic target for atherosclerosis (Su et al., 2009; Tang et 
al., 2008). Some parts of pleitropic action of angiotensin 
converting enzymes are attributable to their "telomere 
protection" effects due to increased telomerase activity, 
EPC differentiation and NO production which is demon-
strated to be through activation of this pathway; a power-
ful evidence for the interchanging cellular events leading 
to atherosclerosis (Xia et al., 2008; Dimmeler et al., 
2001). Longer telomere length in females is also attri-
buted to the estrogen induced TERT phosphorylation via 
activation of PI 3 kinase/AKT pathway (Doshida et al., 
2006). 
TERT participates with other components of telo-
merase subunits to make a functional enzyme. Full 
telomerase assembly is a highly complex process which 





Telomerase associated RNA exert functions beyond just 
being a template for telomerase core protein, as it is also 
involved in providing regions necessary for TERT binding 
and catalytic activity and some motifs important for 
stability and regulation (Collins, 2008). Recently, it has 
been demonstrated that TER can limit telomerase in pri-
mary cells and in cancer cell lines as well (Collins, 2008). 
Balanced amounts of TER and TERT may be needed for 
proper telomerase assembly and function. Possessing 5'-
TMG cap and binding site for Sm proteins, remind the 
same processivity of TER with other RNAs, with small 
variation (Seto, 1999). This 451 - nucleotide RNA should 
be distinguished by RNA processing machine to ignore it 
from processing as mRNA, like addition of poly-
Adenosine tail (Collins, 2008). Pseudouridine modifica-
tions by Box H/ACA, necessary for 3' end processing and 
TER accumulation, in addition with the presence of Sm 
proteins associated with telomerase holoenzyme, indi-
cates a nucleolar stage of telomerase assembly 
(Romanova et al., 2009; Zappulla and Cech, 2009; Wong 
and Collins, 2006). The nucleolus involvement in telo-
merase maturation, cell-cycle and aging control makes 
plurifunctional nucleolus aging as a potential pace for 
aging (Lo et al., 2006). Full assembly of telomerase is a 
dynamic process, in which initial ribonucleoprotein (RNP) 
assembly of TER induces a TER conformational changes 
that promotes TERT binding (Collins, 2008). In human 
cells, this stepwise nucleocytoplasmic shuttling is orches-
trated through exportin CRM1p and members of the 14-3-
3 protein (Ferrezuelo et al., 2002; Gallardo et al., 2008) 
(Kimura et al., 2004). Shuttled TER participate in esta-
blishment of telomerase complex composed of different 
proteins with variety of accessory functions as heat shock 
protein 90 and its co-chaperons. Catalytically active telo-
merase exist in a HSP90- influenced equilibrium of 
assembly, disassembly and subunit degradation (Collins, 
2008). The importance of highly co-ordinate process of 
telomerase assembly is evident by the consequent 
events of DKC1 mutation, seen in Dyskeratosis con-
genital (DC) (Lin et al., 2002). Impaired nucleolar TER 
assembly makes proliferative cells to experience lack of 
functional telomerase, despite of the presence of poten-
tial TERT (Mochizuki et al., 2004).  
The assembled holoenzyme should leave cytoplasm for 
its proper action in nucleus. Intranuclear telomerase 
localization is a highly regulated process, which is depen-
dent on cell cycle stage, transformation and DNA dam-
age (Wong, 2002). Telomerase in and out of the nucleus 
proceeds through nuclear pores via importing/exporting 
complex and the small GTPase Ran (Haendeler et al., 
2003). The GTP- concentration dependency across 
nuclear envelopes for directionality of transport is an 
interesting joint with localization and processivity. In the 
process of endothelial cell dysfunction, oxidative burden 
has been demonstrated to deplete human TERT by 
initiation of nuclear export (Haendeler et al., 2003). 





cells and smooth muscle cells upon stimulation with 
growth factors and proliferative stimuli (Liu et al., 2001; 
Minamino and Kourembanas, 2001).  
In organisms as Saccharomyces cerevisiae, telo-
merase repeat addition processivity is increased at criti-
cally short telomeres, which means that the elongation 
rate by telomerase depends on the danger signals from 
telomeres (Chang et al., 2007). The processivity rate of 
telomerase and the nucleotide addition is more in very 
short telomeres, but it is not analyzed in human with EVA 
syndrome. This alarm dependent strategy results in shift 
from non-extendible to extendible state. Like dNTP 
dependent fidelity of DNA polymerase, it has been shown 
that telomerase processivity is dependent to dGTP 
concentration (Hammond PW). In-depth evaluation of 
these mentioned regulatory networks in endothelial cells 
is needed for better understanding of telomerase dys-
function in promotion of endothelial cell dysfunction.  
Imported telomerase makes a bipartite interaction with 
TER and single- stranded DNA by TERT-specific N- and 
C-terminal extensions from polymerase domains (Lue 
and Peng, 1998; Collins, 2008). Telomerase first binds to 
DNA substrate, aligning the DNA primer 3' end with the 
telomerase RNA template and holding a 5' region for the 
DNA primer in a separate anchor site (Lue and Peng, 
1998). Binding of telomerase to DNA primer, subsequent 
reverse transcription of short RNA template, deoxy-
nucleotide extension, primer translocation and dissocia-
tion will occur (Wyatt et al., 2007). Initiation of telomerase 
cycle needs binding of telomerase to the DNA primer, 
which is controlled negatively or positively, by proteins 
present at the chromosome terminus (Weilbaecher and 
Lundblad, 1999). Absence of these proteins prohibits 
telomere addition, due to the folded back 3' primer and 
buried within this nucleoprotein complex (Weilbaecher 
and Lundblad, 1999).  
Telomeres have some alternative methods rather than 
telomerase for length maintance. Fruit fly, which we are 
indebted to them for major progresses made in telomere 
field, do not use telomerase for cap elongation (Villasante 
et al., 2007). In some organisms, telomere lengthening is 
based on the non-enzymatic telomere elongation mecha-
nisms, as homologues recombination (HR) and non-
homologues end joining replication (NHEJR) (Celli et al., 
2006). This alternative lengthening of telomere (ALT) is 
most evident in tumors and lower organisms. This sister 
chromatid exchange, is not yet seen in endothelial cells in 
the process of atherosclerosis.  
Telomeres are not simply added hexanucleotides. Telo-
meres processing initiated and progressed by Shelterin 
complex step-by-step. The 5 end with the universal ATC-
5 sequence is generated under the precise action of 
POT1 (de Lange, 2005). Invasion of the generated 3 
overhang (100 - 400 nt long) to the adjacent D-loop 
(Duplex) with variable length remodel telomeres into 
duplex lariats, termed T-loops (telomeric) (de Lange, 
2005; Griffith, 1999; Stansel, 2001). This telomere folding  




is mediated by TRF2, preferentially localized to the 
junction between the duplex repeats and the single-
stranded overhang (Stansel, 2001). At this T-loop junc-
tion, TP53 is also co-localized, to facilitate the efficiency 
of TRF2-catalyzed t-loop formation (Zhang et al., 2005). 
Formation of T-loop needs TTAGGG-3' overhang of at 
least six nucleotides, hence 5' overhangs, blunt ends and 
non-telomeric termini are deficient in loop formation 
(Stansel, 2001). Even short telomeres are capable to 
construct protective capping loops in the excess amounts 
of TRF2 (Karlseder et al., 2004). But TRF2 over expre-
ssion prohibits telomeric DNA (tDNA) to repair defects 
and consequent telomere shortening, without any effect 
on genomic DNA (Richter et al., 2007). So, the role of 
TRF2 in telomere maintance is two sides of a coin, with 
unknown underlying mechanisms. Any way, T-loops, 
should be untwined to "open state" and bound POT1 on 
3' overhang should be un-loaded, in order to make 
telomeres accessible to telomeres and permit its action. 
TRF1, facilitator of loop formation, negatively regulate 
telomere length by tight binding to telomeric sequences 
(Hanaoka et al., 2005; Muramatsu et al., 2008). TRF1 
and its 20 –amino acids internally deleted alternative 
spliced variant, Pin2, are involved in maintance of mitotic-
spindle structure (Zhou et al., 2003). Over expression of 
Pin2/TRF1 forces cells toward apoptosis after induction 
of mitosis (Nakamura et al., 2002). Frustrated action of 
Pin2/TRF1 by phosphorylation via ataxia telangiectasia 
mutated (ATM) kinase is an explanation for accelerated 
telomere shortening and mitotic check point defects 
(Nakamura et al., 2002). The Pin2/TRF1 interaction is a 
delicate joint between mitotic-spindle maintance and telo-
mere maintance mechanisms (Nakamura et al., 2002). 
Besides phosphorylation, Pin2/TRF1 function is restricted 
by ADP ribose polymerization via Tankyrase (TANKS1), 
member of poly-(ADP-ribose) polymerase (PARP) family 
(Zhou and Lu, 2001) (Rippmann et al., 2002; Seimiya and 
Smith, 2002). TANKS1 binds to the acidic domain of 
TRF1, through its ankyrin repeats and its failure to func-
tion, as shown in mice, results in anaphase arrest and 
makes telomeres inaccessible to telomerase: hidden telo-
meres (Seimiya and Smith, 2002; Chang et al., 2005). 
Down stream to the TANKS, F-box4 participates in 
degradation of Pin2/TRF1, in accordance with an  
Ubiquitin-Proteasome (Lee et al., 2006). 
The role of shelterin dynamic in telomere shaping and 
function is evident by the studies on the amount of 
shelterin loading and telomere elongation. The reduced 
load of POT1 on short telomeres is associated with 
increased telomerase access (Zaug et al., 2005). 
Considering the capping function of shelterin on terminal 
overhangs arise questions about the enough amounts of 
shelterin for telomere function. It is not determined whe-
ther shelterin function on telomeres is length dependent 
or not.  
In the other hand, telomere repair is not just flipping the 
switch. Repair of the damaged DNA  bases  is  an  NAD+-  




and ATP-dependent mechanism (Petermann et al., 
2003). PARPs, involved in DNA-base excision repair, are 
activated by the induced DNA damages and released 
reactive oxygen species mainly from ischemic tissues 
(Bertram and Hass, 2008). In contrast to their conven-
tional role in keeping genomic stability, hyperactive 
PARPs induce further damage and ROS production via 
promotion of energy crisis. ATP-depletion, one of the 
fundamental insults in the process of endothelial cell 
dysfunction, is promoted by activated PARPs to keep 
genomic stability (Mathews and Berk, 2008). Mutually, 
PARP activity aggravates inflammatory state of endo-
thelial cells by participation in NF-kappaB transactivation 
(Benachour et al., 2007). It also can induce caspase-
independent apoptosis and high- molecular weight DNA 
fragmentation by release of apoptosis-induced factor (van 
Wijk  and Hageman, 2005). It is not clear that which per-
centage of energy is needed for making chromosomal 
stability, but it is apparent that ATP-depleted endothelial 
cells are more susceptible to further imbalance of energy 
stores. Perhaps, the process of DNA repair is income-
pletely performed or even blunted due to the inappro-
priate access to energy supplies. But these hypotheses 
await investigations.  
The huge progresses made in understanding the basic 
concepts of atherosclerosis, seem to be partly due to the 
application of available models. As an age-related 
disease, Hutchinson-Gilford progeria syndrome (HGPS) 
and Wermer disease are suggested as the best candi-
dates for the study of atherosclerosis (Ding and Shen, 
2008). Premature aging and age-related diseases in 
these patients are associated with very short telomeres 
conflicted all cells sparing T lymphocytes (James, 2000). 
But in vitro studies encountered some problems due to 
the rapid entrance of endothelial cells to the senescence 
phase. Human Umbilical Vein Endothelial cells 
(HUVECs) are cells widely used for in vitro studies on 
atherosclerosis. In further studies need to evaluate telo-
merase activity, cells should be harvested in their sub-
confluent phase (Chang et al., 2005). It made some 
difficulty, especially when measures like NO production 
and vWF exocytosis needs to be evaluated in confluent 
endothelial monolayer. So, immortal endothelial cells via 
SV40 and TERT transfection made alternatives for 
researchers. TERT transfection into endothelial cells, in 
order to restore telomerase activity, provided them 
younger phenotypes which overcame the end-replication 
problem (Matsushita et al., 2001). These cells stably 
express surface markers of endothelial cells as CD31, 
CD34, vWF and eNOS and retain functional charac-
teristic of normal cells as responsiveness to angiogenic 
growth stimuli, tube formation on matrigels and regulation 
of NO production and eNOS activation in response to 
extracellular stimuli (Shen et al., 2007). Studies on the 
telomere-attrition related endothelial cell dysfunction, with 
the application of the TERT-transected immortalized cells 





impact of interventions performed on the telomerase 
biology makes some differences with the normal events 
in vivo; an untoward bias in data interpretation.  
Among animal models for studying atherosclerosis, 
pigs and especially knock out mice are used widely. Their 
great appreciable homology to human made them 
suitable candidates, but interestingly their telomere 
biology differs greatly. Both of these animals have telo-
meres longer than humans and in contrast to human, 
most of the mice cells have active telomerase (Houben et 
al., 2008). Extreme telomere length of mice will not shor-
ten with aging and reach critical telomere length just in 
their 6th generation (Cherif et al., 2003; Blasco et al., 
1997). Rat telomeres are relatively long, but in contrast to 
mice shorten with aging (Cherif et al., 2003). Chickens 
have been shown to be intermediate: telomere biology 
like human and telomerase biology like mice (Venkatesan 
and Price, 1998). Among animals, dogs seem more 
applicable, both due to their similar telomere/telomerase 
biology and their availability (Venkatesan and Price, 
1998). So, great attention should be paid in animal selec-
tion based on the study design and also gender- and 
tissue- specific variations in telomere length should also 
be considered. Author suggests the application of Ku86 
knock out mice for studying the effects of telomere 
shortening in the process of atherosclerosis.  
Negligible physiological changes in telomere length 
unrelated to cell division, makes telomere length a major 
indicator of cellular turn over (Rufer et al., 1999). But the 
effect of heritable chromosomal specific as well as 
genetic factors on telomere length arise questions about 
the superiority of measuring individual chromosomal 
versus mean telomere length in reflection of telomere 
kinetic. Among chromosomes, shortest and longest ones 
are attributed to 13p and female Xp, respectively. 
Telomeres shorter than median telomere length were 
observed in 17p while 19p has a telomere length far 
shorter than 17p (Mayer et al., 2006). Accelerated telo-
mere shortening in inactivated X chromosome, is also 
interesting (Surralles et al., 1999). So, based on the 
observed differences in telomere length between indivi-
dual chromosomes, measurement of mean telomere 
length seems more applicable. However, some doubts 
still remain about the application of the average telomere 
length, but we are not to measure shortest telomere 
length of cells. Trusting to mean telomere length, deter-
mination of the candidate cell for its measurement, is of 
great value due to the high intra- and inter- individual 
heterogeneity in intrinsic time table model of telomere 
biology (Baird, 2005). General beliefs are relied on the 
applicability of Leukocyte telomere length (LTL) in mirror-
ing average telomere length of endothelial cells and their 
expansion potential. Off course developmental-stage 
dependent variations in telomere attrition rate within 
human leukocytes and the influential effect of chronic 
inflammation on LTL are not deniable (Frenck, 1998) 





telomere length of these easily accessible cells makes 
ongoing challenge in finding the best candidate. 
Lymphocyte telomere length is longer than granulocyte' 
at birth, due to its stem cell, but telomere shortening is 
accelerated in lymphocytes rather than granulocytes, in 
later stages of life (Rufer et al., 1999). In addition, con-
stant telomere attrition rate of lymphocytes in comparison 
with granulocytes, makes them better reflectors of 
systemic stimuli (Rufer et al., 1999). But in different 
diseases state, the candidate cell for telomere length 
measurement may be variable. It has been demonstrated 
that in type 2 Diabetes Mellitus monocyte telomere length 
reached its critical size while lymphocyte telomere length 
was within its normal length (Sampson et al., 2006). 
Hence, telomere length is a potential marker for develop-
ment of cardiovascular diseases; it needs further studies 
in determination of the candidate cell in different settings 
with predisposition to atherosclerosis.  
Questions about the cause and effect relationship 
between telomere length and risk of the cardiovascular 
diseases, made recent challenges about the efficacy of 
telomere length as predictive marker of coronary artery 
diseases. Off course, due to high inter-individual variation 
in telomere length its application as absolute risk marker 
for cardiovascular diseases needs more attentions. 
However, telomere length is a potential marker for patient 
risk stratification. This mitotic clock may alarm physicians 
for preventive interventions in high risk cases. Hence, the 
absolute benefits of Pravastatin have been demonstrated 
to be greatest in patients with shorter telomere length; 
telomere length may also be applicable as a prognostic 
marker and a guide for personalized medicine (Brouilette 
et al., 2007). To find its position as an absolute marker, 
telomere length follows and longitudinal studies of the 
same individuals are needed, but tedious western blot 
method for measurement of telomere length, made it 
laborious. Emergence of alternative methods as hybridi-
zation protection assay, Q-PCR, primed in situ, FISH, 
chromosome oriented-FISH, flow-FISH and single telo-
mere length analysis (STELA) opened new horizons to 
the famous researches of Leonard Hayflic in 60th (Lin and 
Yan, 2005; Stindl, 2004). Inspite of these progresses, the 
challenge between telomere length and age related 
diseases will be ongoing, since the challenges about aging 
are yet to be tackled. Magnification of normal ageing 
process is needed for understanding its drastic effects. 
But really, our unknown data are more in this regard. As 
tight building syndrome, we do not know which is first in 
the process of aging: I) Telomere shortening or cyto-
plasm contraction and cell size enlargement. II) Are all 
the age related process occurs simultaneously or step by 
step, as first telomere shortening? III) Is there an interval 
between getting the critical telomere length and the 
consequently havoc events or soon after this threshold 
the events happens?  
By increased prevalence of atherosclerosis and its 
complication despite the medical and interventional treat-
ments,   the   emergence   of  new  therapeutic  strategies  is  




needed. Inverse correlation of telomere length with plaque 
grade and numbers of atherosclerosis manifestations marks 
senescence prevention as a novel therapeutic target for 
atherosclerosis (Okuda et al., 2000; Wong et al., 2008). 
Providing a safe harbor for terminal ends in addition to 
unlimited supply of normal human vascular cells will find 
bright future application boards for the telomere related 
vascular diseases. It will be better to reinforce telomere 
capping functions or limit further telomere shortening. 
Strategies based on the over expression of TRF2 or 
potentiation of telomerase activity endow harnessing 
insights. To meet these needs, application of immor-
talizing enzyme, with a half life as long as a day, imparts 
great roles by affording cells with infinite life span and 
delay of cell-cycle exit. The advantages of permanent 
gain of telomerase function should be weighted with its 
potentials in induction of tumerogenic conversion in 
targeted cells. Recently discovered methods for 
"regulated telomerase expression" by Geron, broke the 
limits by making a safe margin for telomerase activity, 
hence no cellular transformation was seen after cellular 
telomerization by forced TERT expression. Another 
approach is application of telomere nanocircles, as arti-
ficial telomere lengthening (Lindstrom et al., 2002). 
Keeping telomere length is also achievable naturally by 
enough intakes of vitamin D and life style modifications, 
as decreasing psychological stress load and appropriate 
physical activity (Tuohimaa, 2009; Fuster and Andres, 
2006; Kadi and Ponsot, 2009). Deep understanding of the 
underlying mechanisms of telomere deregulation and 
telomerase impairment in endothelial cells toward 






Telomere dynamics in the progression and development 
of atherosclerosis delights its targeting as a new therapeutic 
option for cardiovascular diseases. This needs in-depth 
elucidation of the underlying mechanisms of telomere 
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